March 21 (Reuters) - Immutep Ltd (IMM) : IMMUTEP ANNOUNCES UNITED STATES PATENT GRANT FOR EFTILAGIMOD ALPHA IN CANCER
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game